tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

QSAM

QSAM Biosciences to Telix QSAM: Major Merger and Leadership Overhaul
Company AnnouncementsQSAM Biosciences to Telix QSAM: Major Merger and Leadership Overhaul
5M ago
8K
QSAM
QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
PremiumPress Releases
QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
5M ago
QSAM
QSAM Biosciences announces reverse stock split ratio ahead of merger
PremiumThe Fly
QSAM Biosciences announces reverse stock split ratio ahead of merger
5M ago
QSAM
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
PremiumPress Releases
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
8M ago
QSAM
QSAM Biosciences signs term sheet to be acquired by Telix Pharmaceuticals
PremiumThe Fly
QSAM Biosciences signs term sheet to be acquired by Telix Pharmaceuticals
10M ago
QSAM
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
PremiumPress ReleasesQSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
10M ago
QSAM
QSAM Biosciences provides update to shareholders on Phase 1 progress
Premium
The Fly
QSAM Biosciences provides update to shareholders on Phase 1 progress
1y ago
QSAM
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
Premium
Press Releases
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
1y ago
QSAM
QSAM Biosciences adds nuclear reactor at University of Texas to supply chain
PremiumThe Fly
QSAM Biosciences adds nuclear reactor at University of Texas to supply chain
1y ago
QSAM
QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam®
PremiumPress Releases
QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam®
1y ago
QSAM
QSAM Biosciences receives second key patent in Europe for CycloSam
PremiumThe Fly
QSAM Biosciences receives second key patent in Europe for CycloSam
1y ago
QSAM
QSAM Biosciences opens enrollment of second cohort in Phase 1 study of CycloSam
PremiumThe Fly
QSAM Biosciences opens enrollment of second cohort in Phase 1 study of CycloSam
1y ago
QSAM
QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023
PremiumPress ReleasesQSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023
2y ago
QSAM
QSAM receives clearance from FDA to expand enrollment criteria in Phase 1 study
Premium
The Fly
QSAM receives clearance from FDA to expand enrollment criteria in Phase 1 study
2y ago
QSAM
QSAM completes enrollment of initial cohort in Phase 1 study of CycloSam
Premium
The Fly
QSAM completes enrollment of initial cohort in Phase 1 study of CycloSam
2y ago
QSAM
QSAM Biosciences recruits EFCC at MU SOM as upcoming trial site for CycloSam
PremiumThe Fly
QSAM Biosciences recruits EFCC at MU SOM as upcoming trial site for CycloSam
2y ago
QSAM
QSAM Biosciences Recruits the Ellis Fischel Cancer Center at the University of Missouri as Clinical Trial Site to Further Expand and Advance the Study of CycloSam® for Bone Cancer
PremiumPress Releases
QSAM Biosciences Recruits the Ellis Fischel Cancer Center at the University of Missouri as Clinical Trial Site to Further Expand and Advance the Study of CycloSam® for Bone Cancer
2y ago
QSAM
QSAM Biosciences to Present at the Emerging Growth Conference on Wednesday, January 25, 2023
PremiumPress Releases
QSAM Biosciences to Present at the Emerging Growth Conference on Wednesday, January 25, 2023
2y ago
QSAM
QSAM Biosciences focused on completing Phase 1 study in 2023
PremiumThe Fly
QSAM Biosciences focused on completing Phase 1 study in 2023
2y ago
QSAM
QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
PremiumPress ReleasesQSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
2y ago
QSAM
QSAM Biosciences Receives Third U.S. Patent for Clinical-Stage Radiopharmaceutical Drug Candidate CycloSam®
Premium
Press Releases
QSAM Biosciences Receives Third U.S. Patent for Clinical-Stage Radiopharmaceutical Drug Candidate CycloSam®
2y ago
QSAM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >